Recombinant uteroglobin prevents the experimental crescentic glomerulonephritis

Kidney International

Volumn 66, Issue 3, 2004, Pages 1061-1067

  Lee, Dong Sup ^b   Seung, Hee Yang ^b   Hyun, Lee Kim ^b   Kwon, Wook Joo ^b   Chun, Soo Lim ^b   Chae, Dong Wan ^b   Kim, Suhnggwon ^b   Jung, Sang Lee ^b   Yon, Su Kim ^a  

^a Seoul National University   (South Korea)

^b NONE

Author keywords

Experimental crescentic glomerulonephritis; Prevention; Uteroglobin

Indexed keywords

COMPLEMENT COMPONENT C3; CREATININE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; LIPOPOLYSACCHARIDE; RECOMBINANT PROTEIN; UTEROGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; IMMUNE COMPLEX DEPOSITION; IN VITRO STUDY; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA;

EID: 4344586343     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00855.x     Document Type: Article

References (28)

1. KOREAN SOCIETY OF NEPHROLOGY RC: Renal replacement therapy in Korea - Insan Memorial Registry 1998. Korean J Nephrol 18:S343-S354, 1999
2. KITCHING AR, KONG YZ, HUANG XR, et al: Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol 14:1487-1495, 2003
3. WAKAYAMA H, HASEGAWA Y, KAWABE T, et al: Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice. Eur J Immunol 30:1182-1190, 2000
4. ZOUKI C, QUELLET S, FILEP JG: The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. FASEB J 14:572-580, 2000
5. KELLER F, OEHLENBERG B, KUNZENDORF U, et al: Long-term treatment and prognosis of rapidly progressive glomerulonephritis. Clin Nephrol 31:190-197, 1989
6. BONVINI JM, SCHATZMANN U, BECK-SCHIMMER B, et al: Lack of in vivo function of osteopontin in experimental anti-GBM nephritis. J Am Soc Nephrol 11:1647-1655, 2000
7. HISADA Y, SUGAYA T, YAMANOUCHI M, et al: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103:627-635, 1999
8. LE HIR M, HAAS C, MARINO M, RYFFEL B: Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest 78:1625-1631, 1998
9. MIELE L, CORDELLA-MIELE E, MANTILE G, et al: Uteroglobin and uteroglobin-like proteins: The uteroglobin family of proteins. J Endocrinol Invest 17:679-692, 1994
10. MUKHERJEE AB, KUNDU GC, MANTILE-SELVAGGI G, et al: Uteroglobin: A novel cytokine? Cell Mol Life Sci 55:771-787, 1999
11. ZHANG Z, ZIMONJIC DB, POPESCU NC, et al: Human uteroglobin gene: Structure, subchromosomal localization, and polymorphism. DNA Cell Biol 16:73-83, 1997
12. DIERYNCK I, BERNARD A, ROELS H, DE LEY M: Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol 12:205-210, 1995
13. VASANTHAKUMAR G, MANJUNATH R, MUKHERJEE AB, et al: Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection. Biochem Pharmacol 37:389-394, 1988
14. 2 activity. Life Sci 38:1813-1819, 1986
15. HAYWARD A: Who's to blame for asthma? Lancet 346:1243, 1995
16. ZHENG F, KUNDU GC, ZHANG Z, et al: Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nat Med 5:1018-1025, 1999
17. GELBER E, GRANOTH R, FRIDKIN M, et al: A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines. Cancer 92:2172-2180, 2001
18. MORI H, NIWA K, ZHENG Q, et al: Cell proliferation in cancer prevention; effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells. Mutat Res 480:201-207, 2001
19. PHELPS RG: Immune recognition of glomerular antigens. Exp Nephrol 8:226-234, 2000
20. KIM YS, KANG D, KWON DY, et al: Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression. Pharmacogenetics 11:299-305, 2001
21. HSU SI, RAMIREZ SB, WINN MP, et al: Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 57:1818-1835, 2000
22. KRISHNAN RS, DANIEL JC, JR.: "Blastokinin:" Inducer and regulator of blastocyst development in the rabbit uterus. Science 158:490-492, 1967
23. BEIER HM: Uteroglobin: A hormone-sensitive endometrial protein involved in blastocyst development. Biochim Biophys Acta 160:289-291, 1968
24. MIELE L, CORDELLA-MIELE E, FACCHIANO A, MUKHERJEE AB: Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 335:726-730, 1988
25. ZHANG Z, KUNDU GC, YUAN CJ, et al: Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science 276:1408-1412, 1997
26. VOLLMER M, KRAPF R, HILDEBRANDT F: Exclusion of the uteroglobin gene as a candidate for fibronectin glomerulopathy (GFND). Nephrol Dial Transplant 13:2417-2418, 1998
27. FLOEGE J, TOPLEY N, WESSEL K, et al: Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cells. Kidney Int 37:859-869, 1990
28. MARTIN J, LOVETT DH, GEMSA D, et al: Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: Role of interleukin 1. J Immunol 137:525-529, 1986